PRDM1 and hepatocellular carcinoma: To confirm our hypothesis in HCC tissues, we examined the protein levels of BLIMP1, USP22, SPI1, PD-L1, and CD8α using a series of tissue microarrays (TMA) in cohort 2, which contained 90 patients with HCC.